NEW
YORK, March 5, 2024 /PRNewswire/ -- The Gross
Law Firm issues the following notice to shareholders
of BioNTech SE.
Shareholders who purchased shares of BNTX during the class
period listed are encouraged to contact the firm regarding possible
lead plaintiff appointment. Appointment as lead plaintiff is not
required to partake in any recovery.
CONTACT US HERE:
https://securitiesclasslaw.com/securities/biontech-loss-submission-form/?id=69058&from=4
CLASS PERIOD: March 30,
2022 to October 13, 2023
ALLEGATIONS: The complaint alleges that
during the class period, Defendants issued materially false and/or
misleading statements and/or failed to disclose that: (i) BioNTech
overstated demand for and/or the commercial prospects of Comirnaty,
the COVID-19 vaccine developed by the Company in collaboration with
Pfizer ; (ii) the Company and/or Pfizer had accumulated excess
inventory of raw materials for Comirnaty, as well as COVID-19
vaccine doses adapted to other, non-XBB.1.5 variants that were
produced at risk; (iii) accordingly, BioNTech was at an increased
risk of recording significant inventory write-offs and other
charges related to Comirnaty; and (iv) as a result, defendants'
public statements were materially false and/or misleading at all
relevant times.
DEADLINE: March 12, 2024
Shareholders should not delay in registering for this class action.
Register your information here:
https://securitiesclasslaw.com/securities/biontech-loss-submission-form/?id=69058&from=4
NEXT STEPS FOR SHAREHOLDERS: Once you register as a
shareholder who purchased shares of BNTX during the timeframe
listed above, you will be enrolled in a portfolio monitoring
software to provide you with status updates throughout the
lifecycle of the case. The deadline to seek to be a lead plaintiff
is March 12, 2024. There is no cost
or obligation to you to participate in this case.
WHY GROSS LAW FIRM? The Gross Law Firm is a nationally
recognized class action law firm, and our mission is to protect the
rights of all investors who have suffered as a result of deceit,
fraud, and illegal business practices. The Gross Law
Firm is committed to ensuring that companies adhere to responsible
business practices and engage in good corporate citizenship. The
firm seeks recovery on behalf of investors who incurred losses when
false and/or misleading statements or the omission of material
information by a company lead to artificial inflation of the
company's stock. Attorney advertising. Prior results do not
guarantee similar outcomes.
CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (646) 453-8903
View original content to download
multimedia:https://www.prnewswire.com/news-releases/the-gross-law-firm-reminds-biontech-se-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-march-12-2024--bntx-302079269.html
SOURCE The Gross Law Firm